MINI FUTURE SHORT - BOSTON SCIENTIFIC | Real-time Bid/Ask 06:04:31 2024-06-04 am EDT | ||
| 1.82 EUR / 1.97 EUR | +4.70% |
|
| Current month | -2.69% | ||
| 1 month | -12.14% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BOSTON SCIENTIFIC CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-06-04 | 1.82 | +0.55% |
| 24-06-03 | 1.81 | -2.69% |
| 24-05-31 | 1.86 | +0.54% |
| 24-05-30 | 1.85 | -0.54% |
| 24-05-29 | 1.86 | +1.64% |
Delayed Quote Börse Stuttgart
Last update June 04, 2024 at 05:53 am EDT
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BOSTON SCIENTIFIC CORPORATION |
| Issuer | 
BNP Paribas
|
| WKN | PC8ZVT |
| ISIN | DE000PC8ZVT4 |
| Date issued | 2024-04-26 |
| Strike | 95.14 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.03 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.23 € |
|---|---|
| Lowest since issue | 1.64 € |
| Spread | 0.15 € |
| Spread % | 7.61% |
Company Profile
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:
- cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%);
- endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ;
- neuromodulation (2%).
The United States account for 59.2% of net sales.
Sector
-
Ratings for Boston Scientific Corporation
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Boston Scientific Corporation
Sell
Buy
Mean consensus
BUY
Number of Analysts
32
Last Close Price
75.5
USD
Average target price
82.06
USD
Spread / Average Target
+8.69%
- Stock Market
- Certificates
- Certificat
